MEF2C and osteoporosis: This association between ncRNAs and autophagy not only sheds light on the development and progression of diseases but also presents novel perspectives and potential therapeutic targets for disease management (Table 2) (Fig. 2).(1)In the context of osteoporosis treatment, the activation of lncRNA SNHG14 results in elevated levels of Myocyte Enhancer Factor 2C (Mef2c) protein, as well as an increased expression ratio of LC3 II/I and Beclin-1 within BMSCs.